- Home
- NGL vs GHRS Comparison
NGL vs GHRS Comparison
Compare NGL & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGL
- GHRS
- Stock Information
- Founded
- NGL 1940
- GHRS 2018
- Country
- NGL United States
- GHRS Ireland
- Employees
- NGL N/A
- GHRS N/A
- Industry
- NGL Natural Gas Distribution
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- NGL Utilities
- GHRS Health Care
- Exchange
- NGL Nasdaq
- GHRS Nasdaq
- Market Cap
- NGL 751.7M
- GHRS 774.1M
- IPO Year
- NGL 2011
- GHRS 2021
- Fundamental
- Price
- NGL $6.61
- GHRS $12.50
- Analyst Decision
- NGL
- GHRS Strong Buy
- Analyst Count
- NGL 0
- GHRS 8
- Target Price
- NGL N/A
- GHRS $30.63
- AVG Volume (30 Days)
- NGL 787.6K
- GHRS 194.6K
- Earning Date
- NGL 11-11-2025
- GHRS 11-13-2025
- Dividend Yield
- NGL N/A
- GHRS N/A
- EPS Growth
- NGL N/A
- GHRS N/A
- EPS
- NGL N/A
- GHRS N/A
- Revenue
- NGL $3,332,108,000.00
- GHRS N/A
- Revenue This Year
- NGL N/A
- GHRS N/A
- Revenue Next Year
- NGL N/A
- GHRS N/A
- P/E Ratio
- NGL N/A
- GHRS N/A
- Revenue Growth
- NGL 1.08
- GHRS N/A
- 52 Week Low
- NGL $2.64
- GHRS $6.00
- 52 Week High
- NGL $6.71
- GHRS $20.50
- Technical
- Relative Strength Index (RSI)
- NGL 84.91
- GHRS 42.96
- Support Level
- NGL $5.01
- GHRS $11.83
- Resistance Level
- NGL $5.59
- GHRS $13.37
- Average True Range (ATR)
- NGL 0.24
- GHRS 0.75
- MACD
- NGL 0.06
- GHRS -0.09
- Stochastic Oscillator
- NGL 93.87
- GHRS 24.28
About NGL NGL ENERGY PARTNERS LP Common Units representing Limited Partner Interests
NGL Energy Partners LP is a USA-based firm that owns and operates a vertically integrated energy business. The company's operating segments include Crude Oil Logistics, Water Solutions, and Liquids Logistics. It operates crude oil Logistics, owns pipeline injection stations, and offers services for the treatment and disposal of wastewater generated from crude oil and natural gas production, as well as for the disposal of solids, such as tank bottoms and drilling fluids. The firm also supplies natural gas liquids to retailers, wholesalers, refiners, and petrochemical plants and sells propane and distillates.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.